Piramal Pharma Ltd

NSE: PPLPHARMA BSE: 543635

₹161.87

(1.07%)

Sat, 09 May 2026, 02:27 pm

MTF 5xInvest in Piramal Pharma Ltd with 5x Leverage Buy with MTF

Market Cap212.88B

PE Ratio0

Dividend0.09

Health Technology

Pharmaceuticals: Major

24.5K

Piramal Pharma News

Piramal Pharma to Attend Investor Conference on May 27

Piramal Pharma will participate in the 360 ONE Capital 16th Annual Investor Conference - Trinity India 2026 in Mumbai on May 27, 2026.

04 May 2026

companies

Piramal Pharma posts Q4FY26 conference call transcript

Piramal Pharma Limited has made the transcript of its Q4FY26 financial results conference call available on its website, complying with SEBI Regulation 30(6) requirements.

30 Apr 2026

companies

Jefferies Maintains Buy Rating on Piramal Pharma at ₹190

Jefferies maintains Buy rating with ₹190 target despite EBITDA estimate cuts of 8-21% for FY27-28, citing strong CDMO momentum and early-to-mid teens FY27 revenue growth guidance.

30 Apr 2026

companies

Piramal Pharma Eyes ADCs as Key Growth Driver for FY27+

Management highlights ADCs as meaningful growth driver for FY27-28 and beyond, with new customer additions and Phase 3 products strengthening pipeline amid strong medium-term outlook.

30 Apr 2026

companies

Piramal Pharma Makes Q4FY26 Conference Call Recording Available

Piramal Pharma Limited has made the audio recording of its Q4FY26 financial results conference call available on the company website following regulatory compliance requirements.

30 Apr 2026

companies

Showing 1–5 of 73

Rows per page:

Market Current News

Trump Meets ExxonMobil and Chevron Chiefs at White House

Trump reported meeting with ExxonMobil and Chevron chiefs at the White House on Tuesday night, marking a notable engagement between the administration and major US oil companies.

08 May 2026

global

JSW Infrastructure Limited

JSW Infrastructure IPO Fund Utilisation Q4FY26

CARE Ratings flags delay in capex implementation for JSW Infrastructure's Rs. 2,800 crore IPO proceeds; Rs. 2,056.33 crore utilised, Rs. 669.80 crore remains deployed in fixed deposits.

08 May 2026

ipo

Northern Arc Capital Ltd.

Northern Arc Capital Reports No Deviation in IPO Fund Utilisation

Northern Arc Capital Limited has confirmed no deviation in the use of proceeds from its IPO for the quarter ended March 31, 2026. The company raised INR 4,498.45 million via the public issue.

08 May 2026

ipo

Nasdaq 100 Extends Gain To 1.5 Pct

The Nasdaq 100 extended its gains to 1.5%, reflecting upward momentum in the index during the trading session.

08 May 2026

global

Advance Agrolife Limited

Advance Agrolife IPO Fund Utilisation Report Q4FY26

Advance Agrolife's monitoring agency CARE Ratings confirms no deviation in IPO fund utilisation for Q4FY26. Total IPO size Rs. 192.84 crore; Rs. 125.05 crore utilised, Rs. 67.79 crore unutilised.

08 May 2026

ipo

Showing 1–5 of 93505

Rows per page:

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800